Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318670000> ?p ?o ?g. }
- W4318670000 endingPage "431" @default.
- W4318670000 startingPage "420" @default.
- W4318670000 abstract "Old age is associated with increased co-morbidities, resulting in reduced life expectancy. Primary endocrine therapy is an alternative to primary surgical therapy for patients with breast cancer and increased co-morbidities. The aim was to review outcomes of primary endocrine therapy versus primary surgical therapy in older women with breast cancer.PubMed, Embase (Ovid), Scopus, and the Cochrane Library were searched systematically from January 2000 to May 2022. Single-arm studies were excluded. Primary outcomes were overall survival and breast cancer-specific survival. Secondary outcomes were local and regional failure of primary endocrine therapy, recurrence after primary surgical therapy, and health-related quality of life.There were 14 studies including 14 254 patients (primary endocrine therapy 2829, 19.8 per cent; primary surgical therapy 11 425, 80.2 per cent), with the addition of four major studies (9538 patients) compared with the latest review in 2014. Seven studies defined primary surgical therapy as surgery plus adjuvant endocrine therapy, and six studies included patients with oestrogen receptor-positive tumours only. Patients in the primary endocrine therapy group were older than the primary surgical therapy group (mean difference 2.43 (95 per cent c.i. 0.73 to 4.13) years). Primary endocrine therapy led to worse overall survival than primary surgical therapy (HR 1.42, 95 per cent c.i. 1.06 to 1.91). Subgroup analysis of RCTs and prospective studies, however, showed comparable overall survival. Breast cancer-specific survival was also comparable (HR 1.28, 95 per cent c.i. 0.87 to 1.87). At 6 weeks, operated patients had significant arm symptoms and illness burden following major breast surgery compared with patients receiving primary endocrine therapy. Health-related quality of life, measured by the European Organization for Research and Treatment of Cancer QLQ-C30 and EuroQol EQ-5D-5L™, was comparable in the two treatment groups.Overall survival was worse among older women receiving primary endocrine therapy in an analysis including all studies, but comparable in RCTs and prospective studies. This may be due to confounding by age and co-morbidities in retrospective cohort studies of primary endocrine therapy." @default.
- W4318670000 created "2023-02-01" @default.
- W4318670000 creator A5015505200 @default.
- W4318670000 creator A5025457215 @default.
- W4318670000 creator A5068713004 @default.
- W4318670000 creator A5072935988 @default.
- W4318670000 date "2023-01-30" @default.
- W4318670000 modified "2023-10-16" @default.
- W4318670000 title "Revisiting primary endocrine therapy <i>versus</i> surgery in older women with breast cancer: meta-analysis" @default.
- W4318670000 cites W1999108286 @default.
- W4318670000 cites W2009507383 @default.
- W4318670000 cites W2017258870 @default.
- W4318670000 cites W2018134257 @default.
- W4318670000 cites W2033523078 @default.
- W4318670000 cites W2052185376 @default.
- W4318670000 cites W2058681718 @default.
- W4318670000 cites W2059051609 @default.
- W4318670000 cites W2062512553 @default.
- W4318670000 cites W2064097548 @default.
- W4318670000 cites W2066684612 @default.
- W4318670000 cites W2068196254 @default.
- W4318670000 cites W2068635408 @default.
- W4318670000 cites W2074568129 @default.
- W4318670000 cites W2074615857 @default.
- W4318670000 cites W2075642745 @default.
- W4318670000 cites W2077689919 @default.
- W4318670000 cites W2079622077 @default.
- W4318670000 cites W2082547065 @default.
- W4318670000 cites W2088095316 @default.
- W4318670000 cites W2088097351 @default.
- W4318670000 cites W2092326774 @default.
- W4318670000 cites W2118728607 @default.
- W4318670000 cites W2125897651 @default.
- W4318670000 cites W2128771342 @default.
- W4318670000 cites W2148154454 @default.
- W4318670000 cites W2156215866 @default.
- W4318670000 cites W2156612252 @default.
- W4318670000 cites W2157823046 @default.
- W4318670000 cites W2170687251 @default.
- W4318670000 cites W2170892587 @default.
- W4318670000 cites W2214665719 @default.
- W4318670000 cites W2507525628 @default.
- W4318670000 cites W2732996773 @default.
- W4318670000 cites W2946458064 @default.
- W4318670000 cites W2970684805 @default.
- W4318670000 cites W3014103837 @default.
- W4318670000 cites W3027232885 @default.
- W4318670000 cites W3027254171 @default.
- W4318670000 cites W3082873026 @default.
- W4318670000 cites W3085519598 @default.
- W4318670000 cites W3094537424 @default.
- W4318670000 cites W3103148690 @default.
- W4318670000 cites W3128646645 @default.
- W4318670000 cites W3136341943 @default.
- W4318670000 cites W3155306680 @default.
- W4318670000 cites W4220950685 @default.
- W4318670000 cites W4225116295 @default.
- W4318670000 cites W4253917817 @default.
- W4318670000 cites W4285777163 @default.
- W4318670000 doi "https://doi.org/10.1093/bjs/znac435" @default.
- W4318670000 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36718056" @default.
- W4318670000 hasPublicationYear "2023" @default.
- W4318670000 type Work @default.
- W4318670000 citedByCount "0" @default.
- W4318670000 crossrefType "journal-article" @default.
- W4318670000 hasAuthorship W4318670000A5015505200 @default.
- W4318670000 hasAuthorship W4318670000A5025457215 @default.
- W4318670000 hasAuthorship W4318670000A5068713004 @default.
- W4318670000 hasAuthorship W4318670000A5072935988 @default.
- W4318670000 hasConcept C121608353 @default.
- W4318670000 hasConcept C126322002 @default.
- W4318670000 hasConcept C141071460 @default.
- W4318670000 hasConcept C143998085 @default.
- W4318670000 hasConcept C2777982462 @default.
- W4318670000 hasConcept C46699223 @default.
- W4318670000 hasConcept C530470458 @default.
- W4318670000 hasConcept C71315377 @default.
- W4318670000 hasConcept C71924100 @default.
- W4318670000 hasConceptScore W4318670000C121608353 @default.
- W4318670000 hasConceptScore W4318670000C126322002 @default.
- W4318670000 hasConceptScore W4318670000C141071460 @default.
- W4318670000 hasConceptScore W4318670000C143998085 @default.
- W4318670000 hasConceptScore W4318670000C2777982462 @default.
- W4318670000 hasConceptScore W4318670000C46699223 @default.
- W4318670000 hasConceptScore W4318670000C530470458 @default.
- W4318670000 hasConceptScore W4318670000C71315377 @default.
- W4318670000 hasConceptScore W4318670000C71924100 @default.
- W4318670000 hasIssue "4" @default.
- W4318670000 hasLocation W43186700001 @default.
- W4318670000 hasLocation W43186700002 @default.
- W4318670000 hasOpenAccess W4318670000 @default.
- W4318670000 hasPrimaryLocation W43186700001 @default.
- W4318670000 hasRelatedWork W123650933 @default.
- W4318670000 hasRelatedWork W1603749692 @default.
- W4318670000 hasRelatedWork W2028037474 @default.
- W4318670000 hasRelatedWork W2050645819 @default.
- W4318670000 hasRelatedWork W2085014531 @default.
- W4318670000 hasRelatedWork W2224319365 @default.